Table III.

Potential miRNAs in metastatic prostate carcinoma.

Target sequence	Potential microRNA	P-value
hsa_GTGCCTT	miR-506	4.74×10−22
hsa_TATTATA	miR-374	1.52×10−13
hsa_AATGTGA	miR-23A, miR-23B	1.35×10−12
hsa_TGCTGCT	miR-15A, miR-16, miR-15B, miR-195, miR-424, miR-497	2.10×10−12
hsa_TGCCTTA	miR-124A	6.65×10−12
hsa_ACTTTAT	miR-142-5P	1.42×10−11
hsa_TTTGCAC	miR-19A, miR-19B	1.42×10−11
hsa_TGTTTAC	miR-30A-5P, miR-30C, miR-30D, miR-30B, miR-30E-5P	9.49×10−11
hsa_ATGTACA	miR-493	9.49×10−11
hsa_GCAAAAA	miR-129	2.01×10−10
hsa_TTGCCAA	miR-182	2.01×10−10
hsa_CTATGCA	miR-153	6.35×10−10
hsa_TGAATGT	miR-181A, miR-181B, miR-181C, miR-181D	1.68×10−9
hsa_ACATTCC	miR-1, miR-206	2.16×10−9
hsa_CTTTGCA	miR-527	2.39×10−9
hsa_AAGCACT	miR-520F	3.42×10−9
hsa_TGCTTTG	miR-330	5.23×10−9
hsa_ACTGTGA	miR-27A, miR-27B	9.22×10−9
hsa_GTGCCAA	miR-96	1.42×10−8
hsa_AAAGGGA	miR-204, miR-211	2.37×10−8
hsa_TGGTGCT	miR-29A, miR-29B, miR-29C	2.58×10−8
hsa_GTATTAT	miR-369-3P	3.53×10−8
hsa_CATGTAA	miR-496	6.07×10−8
hsa_CTTTGTA	miR-524	7.03×10−8
hsa_AGGAAGC	miR-516-3P	1.09×10−7
hsa_TGCACTG	miR-148A, miR-152, miR-148B	1.98×10−7
hsa_GCTTGAA	miR-498	2.74×10−7
hsa_CAGTATT	miR-200B, miR-200C, miR-429	3.16×10−7
hsa_GTGACTT	miR-224	4.73×10−7
hsa_TGTGTGA	miR-377	5.33×10−7
hsa_TTGCACT	miR-130A, miR-301, miR-130B	5.71×10−7
hsa_ACCAAAG	miR-9	9.58×10−7

miRNA, microRNA.